SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-011224
Filing Date
2017-11-08
Accepted
2017-11-08 17:12:41
Documents
48
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3 2017 q3201710q.htm 10-Q 714258
2 EXHIBIT 10.34 PINNACLE LOAN AGREEMENT loanagreementexhibit1034.htm EX-10.34 190035
3 EXHIBIT 31.1 q32017-exhibit311.htm EX-31.1 16029
4 EXHIBIT 31.2 q32017-exhibit312.htm EX-31.2 16038
5 EXHIBIT 32.1 q32017-exhibit321.htm EX-32.1 8340
  Complete submission text file 0001628280-17-011224.txt   3034266

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cpix-20170930.xml EX-101.INS 442285
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20170930.xsd EX-101.SCH 22627
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20170930_cal.xml EX-101.CAL 48874
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20170930_def.xml EX-101.DEF 83641
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20170930_lab.xml EX-101.LAB 307442
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20170930_pre.xml EX-101.PRE 172498
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 171187482
SIC: 2834 Pharmaceutical Preparations